News • TOM-1 for the brain

This brain protein could put the brakes on Alzheimer’s

Biologists from the University of California, Irvine have made a major finding on combating inflammation linked to Alzheimer's disease.

The School of Biological Sciences researchers’ discovery about the role of a protein called TOM-1 heralds a shift toward examining the molecular underpinnings of Alzheimer’s processes. Their study appears online in Proceedings of the National Academy of Sciences. “Scientists have known for a long time that inflammation is a driver of Alzheimer’s disease, but inflammation is complex and involves many factors,” said School of Biological Sciences Dean Frank LaFerla, Ph.D., whose laboratory conducted the research. “That’s why we decided to look at TOM-1.”

Photo
Alessandra Martini and Frank LaFerla the UCI School of Biological Sciences led the study.
Source: UCI

The protein helps to regulate a key component of the inflammatory response. “We were interested in TOM-1 because its levels are low in the Alzheimer’s brain and in the brains of Alzheimer’s rodent models,” said Alessandra Martini, Ph.D., the paper’s first author and a postdoctoral researcher who worked with LaFerla. “However, its specific role in the disease has largely been unexplored.”

The scientists discovered that reducing the amount of TOM-1 in Alzheimer’s rodent models increased pathology, which included increased inflammation, and exacerbated cognitive problems associated with the disease. Restoring TOM-1 levels reversed those effects. “You can think of TOM-1 as being like the brakes of a car, and the brakes aren’t working for people with Alzheimer’s,” LaFerla said. “This research shows that fixing the brakes at the molecular level could provide an entirely new therapeutic avenue. With millions of people affected by Alzheimers and the numbers growing, we must research a diverse portfolio of approaches so we can one day vanquish this terrible disease.”


Source: University of California, Irvine

08.10.2019

Related articles

Photo

News • Neurodegenerative diseases

Tauopathy or Alzheimer's? Biomarker and PET imaging for improved diagnosis

Researchers have identified biomarkers that, in conjunction with PET imaging, enable doctors to reliably distinguish between primary 4-repeat tauopathies and Alzheimer's disease.

Photo

News • Improving Alzheimer’s disease imaging

Diagnostic sensors overcome blood-brain barrier

Researchers were able to package fluorescent sensors for passage across the blood-brain barrier (BBB) in mice. This holds promise to advance Alzheimer’s disease diagnosis and treatment.

Photo

News • Focus on Toxoplasma gondii

Could brain parasites help treat cognitive disorders?

Toxoplasma gondii is a parasite with the ability to infect the brain, causing life-threatening diseases. Researchers now want to harness its properties to advance treatment of cognitive disorders.

Related products

Subscribe to Newsletter